Sarah Newey

Sarah Newey is a science and health reporter for The Telegraph, focusing on global health issues. She covers topics such as infectious diseases, medical research, and public health policies. Newey has a background in biology and has previously worked for various news outlets.

Biography:  https://www.telegraph.co.uk/authors/s/sa-se/sarah-newey/

98%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

98%

Examples:

  • Sarah Newey tends to present information in a balanced and objective manner.

Conflicts of Interest

98%

Examples:

  • There is no evidence of conflicts of interest in Newey's reporting.

Contradictions

98%

Examples:

  • Newey has not reported any major contradictions in her articles.

Deceptions

98%

Examples:

  • Newey has not employed any deceptive practices in her reporting.

Recent Articles

New Discovery of Heparinoids as Effective Antidote for Cobra Venom: A Potential Solution to Snakebite-Related Disability and Deaths

New Discovery of Heparinoids as Effective Antidote for Cobra Venom: A Potential Solution to Snakebite-Related Disability and Deaths

Broke On: Thursday, 18 July 2024 Scientists from the University of Sydney, Liverpool School of Tropical Medicine, and Instituto Clodomiro Picado discover heparinoids, a class of drugs commonly used as blood thinners, can protect human cells from cobra venom's tissue-damaging toxins. Through CRISPR gene editing technology, they identified that injecting tinzaparin into mice with artificial snakebites reduced tissue damage. If successful in human trials, this could lead to the creation of an affordable and quickly distributable snakebite treatment device containing heparin-like drugs.
Record Number of Streptococcal Toxic Shock Syndrome Cases in Japan: A Surge in Invasive Group A Streptococcus Diseases Post-Covid-19 Restrictions

Record Number of Streptococcal Toxic Shock Syndrome Cases in Japan: A Surge in Invasive Group A Streptococcus Diseases Post-Covid-19 Restrictions

Broke On: Saturday, 01 June 2024 In Japan, a record-breaking 977 cases of streptococcal toxic shock syndrome (STSS) caused by streptococcus pyogenes bacteria have been reported in the first half of 2024. Tokyo is the most affected area with 145 cases. Elderly individuals are particularly susceptible to this rare and deadly infection, which can lead to limb necrosis and multiple organ failure if not treated with antibiotics within 48 hours. The spread of STSS follows a trend seen in other countries after Covid-19 restrictions were lifted.